Jci_page_head_homepage_01 Jci_page_head_homepage_02
Joseph Hinchey, Sunhee Lee, Bo Y. Jeon, Randall J. Basaraba, Manjunatha M. Venkataswamy, Bing Chen, John Chan, Miriam Braunstein, Ian M. Orme, Steven C. Derrick, Sheldon L. Morris, William R. Jacobs, Steven A. Porcelli
Published in Volume 117, Issue 8
J Clin Invest. 2007; 117(8):2279–2288 doi:10.1172/JCI31947
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 5
Protective immunity against virulent M. tuberculosis challenge in guinea pigs following vaccination with ΔsecA2.

(A) Outbred Hartley guinea pigs were vaccinated intradermally with saline, BCG, or ΔsecA2 (n = 5 animals per group) and challenged by aerosol 2 months later with 10–30 CFU of virulent M. tuberculosis H37Rv. Graphs show SEM of CFU of M. tuberculosis in lung, spleen, and mediastinal lymph nodes at 1 and 2 months after challenge for naive (white bars), BCG-vaccinated (gray bars), or ΔsecA2-vaccinated (black bars) animals (CFU counts obtained from a minimum of 3 and in most instances 5 animals; an exception was 2-month spleen CFU for BCG-vaccinated animals, in which counts were obtained from only 1 animal for technical reasons). (B) Quantitative scoring of histopathology graphed as the SEM of the rank scores for the groups of guinea pigs vaccinated and challenged as described in A. Images show representative low-power (×25) views of H&E-stained sections of mediastinal lymph nodes harvested from each group at 1 or 2 months after challenge. Scale bars: 1 mm. *P < 0.05, **P < 0.01, P < 0.001 compared with unvaccinated group or between bracketed groups; 1-way ANOVA with Tukey’s post-hoc test.